 |
Resolution of macular drusen following supplementation with mesozeaxanthin |
Age-related macular degeneration (AMD) is the leading cause of blind registration in people over 50 years of age in the developed world. Late AMD results in loss of central and colour vision, with consequential difficulty in performing fine-detail visual tasks such as reading, driving, and recognizing faces, therefore impacting greatly on one+s independence and quality of life. It is estimated that late AMD affects more than 1.75 million individuals in the United States, and this figure is expected to rise to almost 3 million by 2020.1